Pro Share Advisors LLC Vista Gen Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.12 - $0.3 $272 - $681	-2,273 Reduced 8.54%	24,356 $2,000
Q4 2022 Feb 02, 2023	BUY	$0.09 - $4.8 $464 - $24,792	5,165 Added 24.06%	26,629 $2,000
Q3 2022 Nov 04, 2022	SELL	$0.14 - $4.8 $57 - $1,982	-413 Reduced 1.89%	21,464 $3,000
Q2 2022 Aug 01, 2022	SELL	$0.88 - $1.73 $12,760 - $25,086	-14,501 Reduced 39.86%	21,877 $20,000
Q1 2022 May 10, 2022	SELL	$1.14 - $2.09 $6,854 - $12,567	-6,013 Reduced 14.18%	36,378 $46,000
Q4 2021 Feb 08, 2022	BUY	$1.67 - $2.76 $29,338 - $48,487	17,568 Added 70.77%	42,391 $82,000
Q3 2021 Nov 12, 2021	SELL	$2.62 - $3.45 $64,999 - $85,591	-24,809 Reduced 49.99%	24,823 $68,000
Q2 2021 Aug 13, 2021	BUY	$1.96 - $3.15 $97,278 - $156,340	49,632 New	49,632 $156,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.